Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OVV compared with TAK: revenue, margins and what each company keeps, and the suppliers and customers both name
OVV
Ovintiv Inc.
Change
Mkt cap
Revenue
Revenue
TAK
Takeda Pharmaceutical Co Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
OVV
Ovintiv Inc.
vs
TAK
Takeda Pharmaceutical Co Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
OVV
Ovintiv Inc.
Change
72.61
▲
+1.46%
· post 72.62
Mkt cap
$20.0B
Revenue
$3.0B
Q2 FY26
Revenue
$8.9B
FY25
TAK
Takeda Pharmaceutical Co Ltd
Change
20.92
▲
+4.55%
· post 20.93
Closed
Oct 30 '26
Mkt cap
$36.0B
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
OVV
Ovintiv Inc.
vs
TAK
Takeda Pharmaceutical Co Ltd
72.61
▲
+1.46%
post 72.62
Price
20.92
▲
+4.55%
post 20.93
$20.0B
Mkt cap
$36.0B
Q2 FY26
$3.0B
Revenue
—
FY25
$8.9B
Revenue
—
Change
Change
OVV
72.61
▲
+1.46%
vs
TAK
20.92
▲
+4.55%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
OVV, solid
TAK, dashed
Supply-chain overlap
Revenue flow
TAK: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OVV
6
CUZ
Cousins Properties
supplier
EPM
Evolution Petroleum
customer
—
McDaniel & Associates Consultants
unlisted
supplier
—
Netherland, Sewell & Associates
unlisted
supplier
2 more · OVV chain
›
Shared
0
No shared counterparties.
Only TAK
17
NBIX
Neurocrine Biosciences
customer
EXEL
Exelixis
supplier
PTGX
Protagonist Therapeutics
supplier
DNLI
Denali Therapeutics
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
13 more · TAK chain
›